 |
|
Early Revascularization and Long-term Survival in Cardiogenic Shock Complicating Acute Myocardial Infarction
Judith S. Hochman, MD;
Lynn A. Sleeper, ScD;
John G. Webb, MD;
Vladimir Dzavik, MD;
Christopher E. Buller, MD;
Philip Aylward, MD;
Jacques Col, MD;
Harvey D. White, DSc; for the SHOCK Investigators
JAMA. 2006;295:2511-2515.
Context Cardiogenic shock remains the major cause of death for patients hospitalized with acute myocardial infarction (MI). Although survival in patients with cardiogenic shock complicating acute MI has been shown to be significantly higher at 1 year in those receiving early revascularization vs initial medical stabilization, data demonstrating long-term survival are lacking.
Objective To determine if early revascularization affects long-term survival of patients with cardiogenic shock complicating acute MI.
Design, Setting, and Patients The Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial, an international randomized clinical trial enrolling 302 patients from April 1993 through November 1998 with acute myocardial infarction complicated by cardiogenic shock (mean [SD] age at randomization, 66 [11] years); long-term follow-up of vital status, conducted annually until 2005, ranged from 1 to 11 years (median for survivors, 6 years).
Main Outcome Measures All-cause mortality during long-term follow-up.
Results The group difference in survival of 13 absolute percentage points at 1 year favoring those assigned to early revascularization remained stable at 3 and 6 years (13.1% and 13.2%, respectively; hazard ratio [HR], 0.74; 95% confidence interval [CI], 0.57-0.97; log-rank P = .03). At 6 years, overall survival rates were 32.8% and 19.6% in the early revascularization and initial medical stabilization groups, respectively. Among the 143 hospital survivors, a group difference in survival also was observed (HR, 0.59; 95% CI, 0.36-0.95; P = .03). The 6-year survival rates for the hospital survivors were 62.4% vs 44.4% for the early revascularization and initial medical stabilization groups, respectively, with annualized death rates of 8.3% vs 14.3% and, for the 1-year survivors, 8.0% vs 10.7%. There was no significant interaction between any subgroup and treatment effect.
Conclusions In this randomized trial, almost two thirds of hospital survivors with cardiogenic shock who were treated with early revascularization were alive 6 years later. A strategy of early revascularization resulted in a 13.2% absolute and a 67% relative improvement in 6-year survival compared with initial medical stabilization. Early revascularization should be used for patients with acute MI complicated by cardiogenic shock due to left ventricular failure.
Trial Registration clinicaltrials.gov Identifier: NCT00000552
Author Affiliations: Cardiovascular Clinical Research Center, New York University School of Medicine, New York (Dr Hochman); New England Research Institutes, Watertown, Mass (Dr Sleeper); St Paul's Hospital, Vancouver, British Columbia (Dr Webb); University of Toronto, Toronto, Ontario (Dr Dzavik); Vancouver General Hospital, Vancouver (Dr Buller); Flinders Medical Centre, Bedford Park, Australia (Dr Aylward); Cliniques Universitaires St-Luc, Brussels, Belgium (Dr Col); and Green Lane Hospital, Auckland, New Zealand (Dr White).
RELATED ARTICLE
Cardiogenic Shock
Erin Brender, Cassio Lynm, and Richard M. Glass
JAMA. 2006;295(21):2566.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease.
Lee et al.
Ann. Thorac. Surg. 2008;86:29-34.
ABSTRACT
| FULL TEXT
Cardiogenic Shock: Current Concepts and Improving Outcomes
Reynolds and Hochman
Circulation 2008;117:686-697.
FULL TEXT
Hemodynamic Parameters Are Prognostically Important in Cardiogenic Shock But Similar Following Early Revascularization or Initial Medical Stabilization: A Report From the SHOCK Trial
Jeger et al.
Chest 2007;132:1794-1803.
ABSTRACT
| FULL TEXT
The Calm After the Storm: Long-Term Survival After Cardiogenic Shock
Hochman and Apolito
J Am Coll Cardiol 2007;50:1759-1760.
FULL TEXT
Long-Term Outcome and its Predictors Among Patients With ST-Segment Elevation Myocardial Infarction Complicated by Shock: Insights From the GUSTO-I Trial
Singh et al.
J Am Coll Cardiol 2007;50:1752-1758.
ABSTRACT
| FULL TEXT
The Year in Interventional Cardiology
Dixon et al.
J Am Coll Cardiol 2007;50:270-285.
FULL TEXT
Is Zero the Ideal Death Rate?
Lee et al.
NEJM 2007;357:111-113.
FULL TEXT
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study
Dzavik et al.
Eur Heart J 2007;28:1109-1116.
ABSTRACT
| FULL TEXT
Lack of Benefit From Nitric Oxide Synthase Inhibition in Patients With Cardiogenic Shock: Looking for the Reasons
Ndrepepa et al.
JAMA 2007;297:1711-1713.
FULL TEXT
Effect of Tilarginine Acetate in Patients With Acute Myocardial Infarction and Cardiogenic Shock: The TRIUMPH Randomized Controlled Trial
The TRIUMPH Investigators
JAMA 2007;297:1657-1666.
ABSTRACT
| FULL TEXT
ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
Evid. Based Med. 2006;11:190-190.
FULL TEXT
JournalScan
Malik
Heart 2006;92:1535-1536.
FULL TEXT
Long-Term Benefits of Early Revascularization for Cardiogenic Shock
JWatch Emergency Med. 2006;2006:1-1.
FULL TEXT
Early Revascularization for Cardiogenic Shock: Long-Term Benefit
Journal Watch Cardiology 2006;2006:3-3.
FULL TEXT
What's new in the other general journals.
Fister
BMJ 2006;332:1442-1443.
FULL TEXT
|
